Metraipolis › archive › dc_3eff830ed58c
CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy — Europe PMC PMID:41446278
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41446278
- DOI
- 10.3389/fcimb.2025.1684030
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T19:12:43.672Z
- SHA-256 of the archived text
504c0011e2a63d71028fbf54631cf504b14a14f3442cba9c9ec6968f66ab2386- Stable URL of this page
https://metraipolis.com/documento/dc_3eff830ed58c
How to cite
CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy — Europe PMC PMID:41446278 — Europe PMC (en), https://europepmc.org/article/MED/41446278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3eff830ed58c (Metraipolis archive dc_3eff830ed58c, sha256 504c0011e2a63d71028fbf54631cf504b14a14f3442cba9c9ec6968f66ab2386)
BibTeX
@misc{dc3eff830ed58c,
title = {CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy — Europe PMC PMID:41446278},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41446278},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3eff830ed58c; sha256 504c0011e2a63d71028fbf54631cf504b14a14f3442cba9c9ec6968f66ab2386},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41446278. Agents can read the archived copy with the MCP tool read_document.